Health care worker follow-up compliance after occupational
bloodborne pathogens exposure: A brief report by Díaz, Juan C. & Johnson, Lucas A.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Uniformed Services University of the Health
Sciences U.S. Department of Defense
2016
Health care worker follow-up compliance after
occupational bloodborne pathogens exposure: A
brief report
Juan C. Díaz
Uniformed Services University of the Health Sciences
Lucas A. Johnson
Uniformed Services University of the Health Sciences
Follow this and additional works at: http://digitalcommons.unl.edu/usuhs
This Article is brought to you for free and open access by the U.S. Department of Defense at DigitalCommons@University of Nebraska - Lincoln. It has
been accepted for inclusion in Uniformed Services University of the Health Sciences by an authorized administrator of DigitalCommons@University
of Nebraska - Lincoln.
Díaz, Juan C. and Johnson, Lucas A., "Health care worker follow-up compliance after occupational bloodborne pathogens exposure: A
brief report" (2016). Uniformed Services University of the Health Sciences. 164.
http://digitalcommons.unl.edu/usuhs/164
Brief Report
Health care worker follow-up compliance after occupational
bloodborne pathogens exposure: A brief report
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A retrospective cohort study was conducted examining health care worker (HCW) compliance with Centers
for Disease Control and Prevention recommendations following occupational bloodborne pathogen (BBP)
exposure. HCWs with a BBP exposure from a known HIV- or hepatitis C virus-seropositive individual were
less likely to complete recommended follow-up compared with HCWs with seronegative source patient
exposures (adjusted odds ratio, 0.02 and 0.09, respectively). Continued targeted education and extra vig-
ilance in performing postexposure surveillance are warranted in this higher-risk population.
Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and
Epidemiology, Inc.
BACKGROUND
Exposure to bloodborne pathogens (BBPs) is a well-described oc-
cupational hazard affecting an estimated 385,000 health careworkers
(HCWs) annually.1 Sharps injuries sustained by HCWs while pro-
viding patient care can potentially transmit more than 20 pathogens,
most commonly hepatitis B virus (HBV), hepatitis C virus (HCV), and
HIV.1 An estimated 8% of HCV, 1% of HBV, and 0.5% of HIV infec-
tions in HCWs are directly attributable to occupational sharps
injuries2; risk of seroconversion after percutaneous exposure to se-
ropositive source patients is estimated at 6%-30% for HBV, 0.5%-2%
for HCV, and 0.3% for HIV.3,4
The Centers for Disease Control and Prevention (CDC) recom-
mends health care institutions implement postexposure protocols
for injured HCWs, including assessment of source patients for ev-
idence of HIV, HCV, and HBV infection as well as periodic follow-
up testing andmanagement of the injured HCW.3-5 Although previous
studies demonstrate HCW compliance with performing CDC-
recommended follow-up ranges between 33% and 87%, none have
systematically evaluated factors influencing HCW completion of
follow-up.6,7
METHODS
A retrospective cohort study was designed using de-identified
data routinely collected by the occupational medicine depart-
ment of a large military treatment facility to evaluate clinical and
demographic factors influencing HCW completion of CDC-
recommended follow-up. Subjects were eligible for inclusion if they
reported an occupational BBP exposure to the hospital’s occupa-
tional medicine clinic or emergency room from August 1, 2011-
October 31, 2014. Hospital resident physicians and fellows sustaining
offsite occupational exposures while performing a rotation at another
facility were also eligible for inclusion because hospital policy man-
dated local administrative tracking and management of such
exposures. The surveillance period was from August 1, 2011-
March 31, 2015, to allow subjects to complete a minimum of 6
months of follow-up after exposure. Primary outcome measure
was completion of CDC-recommended management and follow-
up testing defined as completion of all required postexposure
laboratory studies at least once a minimum of 6 months after
exposure.
Analysis of demographic and clinical covariate influence upon
outcome was restricted only to those HCWs who had the oppor-
tunity to complete at least 6 months of follow-up after exposure.
Two separate multivariate models were generated (1 evaluating in-
fluence of HIV source patient seropositivity and 1 for HCV) because
inclusion of both HIV and HCV covariates into a single model re-
sulted in zero cell counts and prohibited performance of logistic
regression. This project was reviewed and approved by the Uni-
formed Services University of the Health Sciences’ Office of Research
(T0873293) and Walter Reed National Military Medical Center In-
stitutional Review Board (408721-1).
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RESULTS
A total of 582 occupational BBP exposures were reported during
the exposure period (Table 1). The majority of exposures involved
source patients with no serologic evidence of HIV (73.6%; n = 428),
HBV (75.3%; n = 438), or HCV (73.2%; n = 426).
Of the 473 subjects whose date of injury afforded a minimum
of 6 months of observation, 88% (n = 414) completed CDC-
recommended follow-up. Institution role, department, injury
location, instrument type, source HIV status, source HCV status, and
infectious diseases department referral were significantly associ-
ated with the outcome on χ2 analysis.
On univariate analysis, HCWs with exposure to a known HIV-
seropositive source were 98% less likely to complete follow-up (odds
ratio [OR], 0.02; 95% confidence interval [CI], 0.01-0.07) when com-
paredwith subjects exposed to a HIV-negative source; these findings
persisted after multivariate adjustment (adjusted OR [aOR], 0.02;
95% CI, 0.004-0.13) (Table 2). Those exposed to source patients with
unknown HIV serostatus demonstrated similarly decreased likeli-
hood of follow-up (aOR, 0.03; 95% CI, 0.01-0.08).
Source patient HCV serostatus similarly influenced likelihood of
follow-up completion. On crude analysis, subjects with exposure
to a known HCV-seropositive source patient were 97% less likely
to complete follow-up when compared with subjects exposed to a
known seronegative HCV source (OR, 0.03; 95% CI, 0.01-0.10); these
findings persisted after multivariate adjustment (aOR, 0.09; 95% CI,
0.02-0.45). Again, those exposed to source patients with unknown
HCV serostatus demonstrated decreased likelihood of follow-up (aOR,
0.02; 95% CI, 0.01-0.06).
DISCUSSION
HCWs with a BBP exposure involving HIV or HCV seropositive
or serostatus unknown patients were less likely to complete follow-
up compared with HCWs exposed to seronegative source patients.
At least 2 possible explanations exist for these surprising findings.
First, the study design necessarily resulted in differential outcome
assessment bias because a seronegative source exposure resulted
in achieving outcome status with relative ease (essentially at time
of presentation) compared with an HCW with an HIV- or HCV-
seropositive source exposure requiring 6 months of follow-up to
achieve outcome status. A second possible explanation can be found
in the health belief model, a psychological model evaluating be-
havior using the 3 constructs of threat perception, benefit perception,
and perceived disadvantage.8 Per hospital protocol, HCWs exposed
to known HIV or HCV patients received consultation with infec-
tious diseases specialists who perform a review of source patient
infectivity, including a review of source patient viral suppressive
therapy and viral load (data unavailable to the hospital occupa-
tional medicine clinic). It is possible that follow-up compliance may
be affected by an HCWs low-perceived susceptibility following de-
livery of these data during specialist assessment; however, the de-
identified data source utilized for this study prevented retrospective
record review to explore such a hypothesis.
Interpretation of this study is subject to several limitations. BBP
exposures are historically underreported. Despite an institutional
policymandating self-reporting, undoubtedly some individuals chose
not to report a BBP exposure. Additionally, exposed HCWs with a
sophisticated understanding of BBP exposure risk may self-stratify,
resulting in an overly complaint cohort more motivated to com-
plete therapy. Several demographic factors (eg, age, sex, race, and
assessment of personal protective equipment use) were not sys-
tematically recorded and were unavailable for analysis. Finally, the
study design resulted in differential observation time for exposed
HCWs based on source serostatus.
Postexposure programs are essential to sustaining a healthywork-
force and preventing pathogen transmission. These study results
highlight need for further research tomore completely assess factors
differentially influencing the personalmotivations for complyingwith
recommended follow-up after BBP exposures, particularly for pa-
tients with higher-risk exposures.
Table 1
Characteristics of health care workers with reported bloodborne pathogens expo-
sure, by completion of follow-up
Risk factor
n (%)
Completion of
follow-up*
χ2 P value
Yes (%) No (%)
414 (87.5) 59 (12.5)
N = 582 Total 473
Employment status .08
Active duty 436 (74.9) 310 (87.3) 45 (12.7)
Civilian 45 (7.7) 40 (93.0) 3 (7.0)
Contractor 66 (11.3) 45 (86.5) 7 (13.5)
General schedule 34 (5.8) 19 (86.4) 3 (13.6)
Unknown 1 (.2) 0 (0.0) 1 (100.0)
Institution role .01
Medical student 23 (4.0) 17 (94.4) 1 (5.6)
Midlevel provider 19 (3.3) 14 (87.5) 2 (12.5)
Nurse 124 (21.3) 91 (91.9) 8 (8.1)
Physician 161 (27.7) 127 (90.1) 14 (9.9)
Medical technician 201 (34.5) 129 (83.8) 25 (16.2)
Other 54 (9.3) 36 (80.0) 9 (20.0)
Department .02
Dental 34 (5.8) 24 (88.9) 3 (11.1)
Fire/police 3 (.5) 1 (33.3) 2 (66.7)
Housekeeping 21 (3.6) 14 (82.4) 3 (17.6)
Medicine 239 (41.1) 173 (87.4) 25 (12.6)
Offsite 17 (2.9) 11 (73.3) 4 (26.7)
SPD 25 (4.3) 15 (75.0) 5 (25.0)
Surgery 239 (41.1) 172 (91.0) 17 (9.0)
Unknown 4 (.7) 4 (100.0) 0 (0.0)
Injury location <.01
Arm 23 (4.0) 17 (89.5) 2 (10.5)
Eye/face/mouth 118 (20.3) 79 (81.4) 18 (18.6)
Hand/finger 423 (72.7) 310 (90.4) 33 (9.6)
Leg 9 (1.5) 4 (66.7) 2 (33.3)
Other 9 (1.5) 4 (50.0) 4 (50.0)
Instrument type <.01
Blade 42 (7.2) 32 (94.1) 2 (5.9)
Hollow needle 190 (32.6) 141 (91.0) 14 (9.0)
Instrument 77 (13.2) 51 (85.0) 9 (15.0)
Needle, unknown type 22 (3.8) 19 (90.5) 2 (9.5)
Solid needle 126 (21.6) 97 (94.2) 6 (5.8)
Splash 114 (19.6) 65 (73.0) 24 (27.0)
Other 11 (1.9) 9 (81.8) 2 (18.2)
Source HIV rapid test <.01
Negative 428 (73.6) 338 (96.8) 11 (3.2)
Positive 17 (2.9) 6 (37.5) 10 (62.5)
Unknown 137 (23.5) 70 (64.8) 38 (35.2)
Source hepatitis C status <.01
Negative 426 (73.2) 337 (97.4) 9 (2.6)
Positive 14 (2.4) 7 (50.0) 7 (50.0)
Unknown 142 (24.4) 70 (61.9) 43 (38.1)
Source hepatitis B status .43
Negative 438 (75.3) 341 (95.3) 17 (4.7)
Positive 3 (.5) 3 (100.0) 0 (0.0)
Unknown 141 (24.2) 70 (62.5) 42 (37.5)
Infectious diseases
department referral
<.01
No 537 (92.3) 392 (90.1) 43 (9.9)
Yes 45 (7.7) 22 (57.9) 16 (42.1)
Placed on PEP .13
No 17 (37.8) 7 (46.7) 8 (53.3)
Yes 28 (62.2) 15 (65.2) 8 (34.8)
PEP, post exposure prophylaxis.
*Completion of follow-up restricted to subjects with at least 6 months of observa-
tion after exposure (August 1,2011-March 31, 2014).
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Table 2
Health care worker crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for completion of follow-up after occupational bloodborne pathogen exposure:
HIV and hepatitis C virus (HCV) models
Characteristics
HIV model HCV model
Crude OR Adjusted model*
P value
Crude odds ratio Adjusted model*
P valueOR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Institution role
Medical student Reference category Reference category Reference category Reference category
Midlevel provider 0.82 (0.10-6.62) 0.60 (0.03-10.79) .73 0.82 (0.10-6.62) 1.21 (0.05-28.61) .91
Nurse 1.34 (0.26-6.86) 2.08 (0.18-24.62) .56 1.34 (0.26-6.86) 2.40 (0.20-29.39) .49
Physician 1.07 (0.22-5.11) 1.44 (0.13-16.49) .77 1.07 (0.22-5.11) 1.28 (0.11-14.93) .85
Tech/corpsman/medic 0.61 (0.13-2.79) 1.45 (0.14-14.98) .76 0.61 (0.13-2.79) 1.65 (0.15-17.71) .68
Other 0.47 (0.09-2.42) 1.89 (0.12-29.82) .65 0.47 (0.09-2.42) 3.14 (0.19-53.29) .43
Department
Surgery Reference category Reference category Reference category Reference category
Fire/police 0.05 (0.01-0.60) 0.09 (0.01-2.37) .15 0.05 (0.01-0.60) 0.41 (0.003-61.39) .73
Housekeeping 0.49 (0.13-1.86) 1.73 (0.19-16.19) .63 0.49 (0.13-1.86) 1.64 (0.17-15.82) .67
Medicine 0.72 (0.38-1.38) 0.69 (0.25-1.90) .48 0.72 (0.38-1.38) 0.78 (0.29-2.13) .63
Offsite 0.29 (0.08-1.00) 1.12 (0.19-6.83) .9 0.29 (0.08-1.00) 1.04 (0.16-6.77) .97
SPD 0.31 (0.10-0.97) 2.07 (0.42-10.24) .37 0.31 (0.10-0.97) 2.37 (0.47-12.05) .3
Dental 0.84 (0.23-3.06) 1.36 (0.17-10.76) .77 0.84 (0.23-3.06) 1.65 (0.22-12.40) .63
Injury location
Hand or finger Reference category Reference category Reference category Reference category
Arm 0.93 (0.21-4.21) 2.49 (0.20-30.51) .48 0.93 (0.21-4.21) 0.67 (0.10-4.50) .68
Eye/face/mouth 0.48 (0.26-0.90) 1.44 (0.29-7.15) .66 0.48 (0.26-0.90) 1.43 (0.26-7.89) .68
Other 0.11 (0.03-0.46) 0.14 (0.01-1.56) .11 0.11 (0.03-0.46) 0.18 (0.02-2.06) .17
Leg 0.22 (0.04-1.24) 0.28 (0.02-3.84) .34 0.22 (0.04-1.24) 0.94 (0.07-12.97) .94
Instrument type
Solid needle Reference category Reference category Reference category Reference category
Blade 0.99 (0.19-5.15) 2.46 (0.37-16.15) .35 0.99 (0.19-5.15) 3.04 (0.41-22.67) .28
Hollow needle 0.62 (0.23-1.68) 1.16 (0.30-4.52) .83 0.62 (0.23-1.68) 1.44 (0.37-5.63) .6
Instrument 0.35 (0.12-1.04) 0.31 (0.07-1.41) .13 0.35 (0.12-1.04) 0.51 (0.11-2.31) .38
Needle, unknown type 0.59 (0.11-3.14) 1.41 (0.19-10.37) .74 0.59 (0.11-3.14) 1.35 (0.19-9.32) .76
Other 0.28 (0.05-1.59) 0.92 (0.10-8.42) .94 0.28 (0.05-1.59) 1.15 (0.13-9.84) .9
Splash 0.17 (0.07-0.43) 0.17 (0.03-1.11) .06 0.17 (0.07-0.43) 0.18 (0.03-1.20) .08
Source rapid HIV test
Negative Reference category Reference category Reference category Reference category
Positive 0.02 (0.01-0.07) 0.02 (0.004-0.13) <.01 0.03 (0.01-0.10) 0.09 (0.02-0.45) <.01
Unknown 0.07 (0.03-0.13) 0.03 (0.01-0.08) <.01 0.05 (0.02-0.10) 0.02 (0.01-0.06) <.01
Referral to infectious diseases department
No Reference category Reference category Reference category Reference category
Yes 0.15 (0.08-0.32) 0.41 (0.12-1.39) .15 0.15 (0.08-0.32) 0.12 (0.04-0.37) <.01
SPD, sterile processing.
*Models include institution role, department, injury location, instrument type, source rapid HIV test, and infectious diseases referral.
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